Literature DB >> 11588040

A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.

C Ruiz1, C Y Liu, Q H Sun, M Sigaud-Fiks, E Fressinaud, J Y Muller, P Nurden, A T Nurden, P J Newman, N Valentin.   

Abstract

This article reports a Glanzmann thrombasthenia (GT) patient, N.M., with a point mutation in the third cysteine-rich repeat of beta3-integrin or platelet glycoprotein (GP) IIIa, leading to the expression of a constitutively activated fibrinogen receptor. The diagnosis of GT was based on a severely reduced platelet-aggregation response to a series of agonists and approximately 20% of surface-expressed GPIIb-IIIa. The patient's GPIIb-IIIa constitutively expressed epitopes recognized by antibodies to ligand-induced binding sites (LIBS) and also spontaneously bound the fibrinogen-mimetic antibody, PAC-1. Furthermore, significant amounts of bound fibrinogen were detected on his platelets ex vivo. No signs of platelet activation were observed on sections of unstimulated platelets from N.M. by electron microscopy. Immunogold labeling highlighted the presence of surface-bound fibrinogen but revealed platelet heterogeneity with regard to the surface density. When the patient's platelets were stimulated by thrombin-receptor activating peptide, amounts of surface-expressed GPIIb-IIIa increased and the aggregation response improved, although it failed to normalize. Platelets from N.M. were able to adhere and spread on immobilized fibrinogen. Sequence analysis of genomic DNA from N.M. revealed a homozygous g1776T>C mutation in GPIIIa, leading to a Cys560Arg amino acid substitution. A stable Chinese hamster ovary (CHO) cell line was prepared expressing surface GPIIb-Arg560IIIa. Like platelets from the patient, GPIIb-Arg560IIIa-transfected CHO cells constitutively bound LIBS antibodies and PAC-1. They also showed an enhanced ability to adhere on surface-bound fibrinogen. Overall, these data demonstrate that a gain-of-function mutation can still be associated with a thrombasthenic phenotype even though platelets show spontaneous fibrinogen binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588040     DOI: 10.1182/blood.v98.8.2432

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit.

Authors:  Tetsuji Kamata; Hironobu Ambo; Wilma Puzon-McLaughlin; Kenneth Khiem Tieu; Makoto Handa; Yasuo Ikeda; Yoshikazu Takada
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 2.  Regulation of platelet beta 3 integrins.

Authors:  Joel S Bennett; David T Moore
Journal:  Haematologica       Date:  2010-07       Impact factor: 9.941

3.  Identification of integrin beta subunit mutations that alter affinity for extracellular matrix ligand.

Authors:  Timmy Kendall; Leona Mukai; Alison L Jannuzi; Thomas A Bunch
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

4.  The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.

Authors:  Karen Vanhoorelbeke; Simon F De Meyer; Inge Pareyn; Chantal Melchior; Sebastien Plançon; Christiane Margue; Olivier Pradier; Pierre Fondu; Nelly Kieffer; Timothy A Springer; Hans Deckmyn
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

Review 5.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

6.  C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.

Authors:  J Fang; P Nurden; P North; A T Nurden; L M Du; N Valentin; D A Wilcox
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 7.  Talin and kindlin: the one-two punch in integrin activation.

Authors:  Feng Ye; Adam K Snider; Mark H Ginsberg
Journal:  Front Med       Date:  2014-01-29       Impact factor: 4.592

Review 8.  Thiol isomerases in thrombus formation.

Authors:  Bruce Furie; Robert Flaumenhaft
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

9.  Diagnosis and Management of Inherited Platelet Disorders.

Authors:  Carl Maximilian Kirchmaier; Daniele Pillitteri
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

Review 10.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.